Mitochondrial myopathies caused by prolonged use of telbivudine

논문상세정보
    • 저자 이종목 신진홍 박영은 김대성
    • 제어번호 103570423
    • 학술지명 Annals of Clinical Neurophysiology
    • 권호사항 Vol. 19 No. 1 [ 2017 ]
    • 발행처 대한임상신경생리학회
    • 자료유형 학술저널
    • 수록면 40-45
    • 언어 English
    • 출판년도 2017
    • KDC 511.1805
    • 등재정보 KCI등재
    • 판매처
    유사주제 논문( 0)

' Mitochondrial myopathies caused by prolonged use of telbivudine' 의 참고문헌

  • Two cases of telbivudine-induced myopathy in siblings with chronic hepatitis B
    Eun Hye Kim Clinical and Molecular Hepatology 19 1 82-86 [2013]
  • The natural history of chronic hepatitis B virus infection
    McMahon BJ Hepatology 49 5 Suppl S45-S55 [2009]
  • Telbivudine myopathy in a patient with chronic hepatitis B
    Wang M Int J Clin Pharm 34 422-425 [2012]
  • Natural history of chronic hepatitis B : special emphasis on disease progression and prognostic factors
    Fattovich G J Hepatol 48 335-352 [2008]
  • Mitochondrial myopathy caused by long-term zidovudine therapy
    Dalakas MC N Engl J Med 322 1098-1105 [1990]
  • Long-term therapy with clevudine for chronic hepatitis B can be associated with myopathy characterized by depletion of mitochondrial DNA
    Seok JI Hepatology 49 2080-2086 [2009]
  • Entecavir-associated myopathy : a case report and literature review
    Yuan K Muscle Nerve 49 610-614 [2014]
  • Entecavir for treatment of hepatitis B virus displays no in vitro mitochondrial toxicity or DNA polymerase gamma inhibition
    Mazzucco CE Antimicrob Agents Chemother 52 598-605 [2008]
  • Continuous single motor unit electromyographic activity in adefovir associated myopathy
    Lo YL J Clin Neurosci 15 1073-1074 [2008]
  • Clinicopathological features of telbivudine-associated myopathy
    Ambang T PLoS ONE 11 e0162760- [2016]
  • Clinical, histological and molecular reversibility of zidovudine myopathy
    Masanés F J Neurol Sci 159 226-228 [1998]
  • Clinical features and risk factors of creatine kinase elevations and myopathy associated with telbivudine
    Zou XJ J Viral Hepat 18 892-896 [2011]
  • 2-year GLOBE trial results: telbivudine is superior to lamivudine in patients with chronic hepatitis B
    Liaw YF Gastroenterology 136 486-495 [2009]